Figure 2 : Plasma concentration-time profiles of empagliflozin after administration of empagliflozin with or without glimepiride.

Macha et al.Journal of Diabetes Research and Clinical Metabolism  2012 1:14DOI : 10.7243/2050-0866-1-14